| Mrs Amanda Jean Kouba, LCSW | |
|
919 S 7th St Ste 401, Bismarck, ND 58504-5835 | |
| (000) 000-0000 | |
| Not Available |
| Full Name | Mrs Amanda Jean Kouba |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 7 Years |
| Location | 919 S 7th St Ste 401, Bismarck, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528577814 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 5156 (North Dakota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Transitions Healthcare Pllc | 1153736160 | 3 |
News Archive
News outlets report on the pharmaceutical industry's involvement in doctor training and its role in shaping the health care overhauls pending in Congress.
Results from Cytori Therapeutics' preclinical fat grafting study have been published in the February issue of the Annals of Plastic Surgery. This article, entitled "Supplementation of Fat Grafts with Adipose-Derived Regenerative Cells (ADRCs) Improves Long-Term Graft Retention," examines the science behind cell-enriched autologous fat grafting and its application to cosmetic and reconstructive surgery. The results demonstrate a doubling in graft retention in cell-enriched grafts and provide insight into the mechanisms behind this improvement.
It's broadly assumed that cells degrade and recycle their own old or damaged organelles, but researchers at University of California, San Diego School of Medicine, The Johns Hopkins University School of Medicine and Kennedy Krieger Institute have discovered that some neurons transfer unwanted mitochondria - the tiny power plants inside cells - to supporting glial cells called astrocytes for disposal.
Use of the blood clot-inhibiting medication tifacogin does not appear to improve outcomes of patients with severe community-acquired pneumonia, according to a study conducted by researchers from North and South America, Europe, Asia and Africa. The drug had shown some potential benefit in the sCAP subgroup of an earlier trial involving sepsis patients.
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
› Verified 5 days ago
| Entity Name | Transitions Healthcare Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992304695 PECOS PAC ID: 1153736160 Enrollment ID: O20210224000705 |
News Archive
News outlets report on the pharmaceutical industry's involvement in doctor training and its role in shaping the health care overhauls pending in Congress.
Results from Cytori Therapeutics' preclinical fat grafting study have been published in the February issue of the Annals of Plastic Surgery. This article, entitled "Supplementation of Fat Grafts with Adipose-Derived Regenerative Cells (ADRCs) Improves Long-Term Graft Retention," examines the science behind cell-enriched autologous fat grafting and its application to cosmetic and reconstructive surgery. The results demonstrate a doubling in graft retention in cell-enriched grafts and provide insight into the mechanisms behind this improvement.
It's broadly assumed that cells degrade and recycle their own old or damaged organelles, but researchers at University of California, San Diego School of Medicine, The Johns Hopkins University School of Medicine and Kennedy Krieger Institute have discovered that some neurons transfer unwanted mitochondria - the tiny power plants inside cells - to supporting glial cells called astrocytes for disposal.
Use of the blood clot-inhibiting medication tifacogin does not appear to improve outcomes of patients with severe community-acquired pneumonia, according to a study conducted by researchers from North and South America, Europe, Asia and Africa. The drug had shown some potential benefit in the sCAP subgroup of an earlier trial involving sepsis patients.
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
› Verified 5 days ago
| Entity Name | Wildflower Mental Health Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710751607 PECOS PAC ID: 7113363458 Enrollment ID: O20240309000051 |
News Archive
News outlets report on the pharmaceutical industry's involvement in doctor training and its role in shaping the health care overhauls pending in Congress.
Results from Cytori Therapeutics' preclinical fat grafting study have been published in the February issue of the Annals of Plastic Surgery. This article, entitled "Supplementation of Fat Grafts with Adipose-Derived Regenerative Cells (ADRCs) Improves Long-Term Graft Retention," examines the science behind cell-enriched autologous fat grafting and its application to cosmetic and reconstructive surgery. The results demonstrate a doubling in graft retention in cell-enriched grafts and provide insight into the mechanisms behind this improvement.
It's broadly assumed that cells degrade and recycle their own old or damaged organelles, but researchers at University of California, San Diego School of Medicine, The Johns Hopkins University School of Medicine and Kennedy Krieger Institute have discovered that some neurons transfer unwanted mitochondria - the tiny power plants inside cells - to supporting glial cells called astrocytes for disposal.
Use of the blood clot-inhibiting medication tifacogin does not appear to improve outcomes of patients with severe community-acquired pneumonia, according to a study conducted by researchers from North and South America, Europe, Asia and Africa. The drug had shown some potential benefit in the sCAP subgroup of an earlier trial involving sepsis patients.
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Amanda Jean Kouba, LCSW 2401 46th Ave Se Ste 201, Mandan, ND 58554-4829 Ph: (701) 699-4052 | Mrs Amanda Jean Kouba, LCSW 919 S 7th St Ste 401, Bismarck, ND 58504-5835 Ph: (000) 000-0000 |
News Archive
News outlets report on the pharmaceutical industry's involvement in doctor training and its role in shaping the health care overhauls pending in Congress.
Results from Cytori Therapeutics' preclinical fat grafting study have been published in the February issue of the Annals of Plastic Surgery. This article, entitled "Supplementation of Fat Grafts with Adipose-Derived Regenerative Cells (ADRCs) Improves Long-Term Graft Retention," examines the science behind cell-enriched autologous fat grafting and its application to cosmetic and reconstructive surgery. The results demonstrate a doubling in graft retention in cell-enriched grafts and provide insight into the mechanisms behind this improvement.
It's broadly assumed that cells degrade and recycle their own old or damaged organelles, but researchers at University of California, San Diego School of Medicine, The Johns Hopkins University School of Medicine and Kennedy Krieger Institute have discovered that some neurons transfer unwanted mitochondria - the tiny power plants inside cells - to supporting glial cells called astrocytes for disposal.
Use of the blood clot-inhibiting medication tifacogin does not appear to improve outcomes of patients with severe community-acquired pneumonia, according to a study conducted by researchers from North and South America, Europe, Asia and Africa. The drug had shown some potential benefit in the sCAP subgroup of an earlier trial involving sepsis patients.
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
› Verified 5 days ago
Brooke Leanne Joritz, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2700 State St Ste F, Bismarck, ND 58503 Phone: 701-895-4685 | |
Kellie Hoffman, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 619 Riverwood Dr Ste 105, Bismarck, ND 58504 Phone: 701-224-9751 | |
Jackie Marie Lelm, LICSW, MSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1237 W Divide Ave, Ste 5, Bismarck, ND 58501 Phone: 701-328-8843 Fax: 701-328-8900 | |
Darla J Stafford, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1800 E Interstate Ave Ste B, Bismarck, ND 58503 Phone: 701-323-6543 Fax: 701-323-5492 | |
Elisabeth Oldham, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1310 E Main Ave, Bismarck, ND 58501 Phone: 701-530-7195 | |
Debra M. Bosch, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1701 Burnt Boat Dr, Second Floor, Bismarck, ND 58503 Phone: 701-323-0924 Fax: 701-323-0935 | |
Nikki Marie Mundahl, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 315 N 11th St, Bismarck, ND 58501 Phone: 218-329-7097 |